We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Zur Rose Aerzte AG (ROSE) CHF5.75

Sell:365.50 CHF Buy:366.00 CHF Change: 29.00 CHF (8.61%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:365.50 CHF
Buy:366.00 CHF
Change: 29.00 CHF (8.61%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:365.50 CHF
Buy:366.00 CHF
Change: 29.00 CHF (8.61%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Contact details

Address:
Walzmuehlestrasse 60
FRAUENFELD
8500
Switzerland
Telephone:
+41 (52) 7240020
Website:
https://www.zurrosegroup.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ROSE
ISIN:
CH0042615283
Market cap:
3.55 billion CHF
Shares in issue:
9.58 million
Sector:
Drug Retail
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
n/a

Key personnel

  • Walter Oberhaensli
    Chief Executive Officer, Chairman of the Management Board, Executive Director
  • Marcel Ziwica
    Chief Financial Officer, Member of the Management Board
  • Bernd Gschaider
    Chief Operations Officer, Member of the Management Board
  • Walter Hess
    Member of the Management Board, Head - Germany
  • Emanuel Lorini
    Member of the Management Board, Head - Switzerland
  • David Maso
    Member of the Management Board, Head Europe
  • Betul Unaran
    Member of the Management Board, Chief Strategy and Digital Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.